Joshua W. Ohde

Joshua W. Ohde

Auto-generated profile, based on publicly available information

Joshua W. Ohde

Center for Digital Health, Mayo Clinic, Rochester, MN, United States

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2025 in NEJM AI
Verified
Journal Article
Closed access
JOJoshua W. Ohde
Joshua W. Ohde
LRLauren M. Rost
Lauren M. Rost
JOJoshua D. Overgaard
Joshua D. Overgaard

TJThulasee Jose
Thulasee Jose
JOJoshua W. Ohde
Joshua W. Ohde
JHJ. Taylor Hays
J. Taylor Hays
MBMichael V. Burke
Michael V. Burke
DWDavid O. Warner
David O. Warner
Continued tobacco use after cancer diagnosis is detrimental to treatment and survivorship. The current reach of evidence-based tobacco treatments in cancer patients is low. As a part of the National Cancer Institute Cancer Center Cessation Initiative, the Mayo Clinic Cancer Center designed an electronic health record (EHR, Epic©)-based process to automatically refer ambulatory oncology patients to tobacco use treatment, regardless of intent to cease tobacco use(“opt out”). The referral and patient scheduling, accomplished through a best practice advisory (BPA) directed to staff who room patients, does not require a co-signature from clinicians. This process was piloted for a six-week period starting in July of 2019 at the Division of Medical Oncology, Mayo Clinic, Rochester, MN. All oncology patients who were tobacco users were referred for tobacco treatment by the rooming staff (n = 210). Of these, 150 (71%) had a tobacco treatment appointment scheduled, and 25 (17%) completed their appointment. We conclude that an EHR-based “opt-out” approach to refer patients to tobacco dependence treatment that does not require active involvement by clinicians is feasible within the oncology clinical practice. Further work is needed to increase the proportion of scheduled patients who attend their appointments.

16 June 2025 in Journal of Medical Internet Research
Verified
Journal Article
Open access
MWMochammad Fadjar Wibowo
Mochammad Fadjar Wibowo
APAlexandra Pyle
Alexandra Pyle
ELEmma Lim
Emma Lim
JOJoshua W Ohde
Joshua W Ohde
Nan LiuNan Liu
Nan Liu
JKJonas Karlström
Jonas Karlström
Background: Artificial intelligence (AI) holds potential to enhance health systems worldwide. However, its implementation in health systems in Southeast Asia (SEA)—a region of diverse geopolitical and socioeconomic development—has been understudied. Objective: This study aims to gain insights into the current state and future prospects of AI technology from participants most directly involved in its adoption across health systems in SEA whose perspectives have received limited attention in research to date. Methods: We used a cross-sectional qualitative research design. Data were collected through 31 semistructured interviews with participants working in or significantly involved with the implementation of AI-enabled technologies within health systems across 7 SEA countries: Brunei Darussalam, Indonesia, Myanmar, Singapore, Thailand, Vietnam, and the Philippines. The participants represented the public, private, and nonprofit sectors. They included innovators, health care professionals using AI, professionals from nongovernmental and multilateral organizations, corporate professionals, academics, policy makers, regulators, and investors. All interviews were audio recorded and transcribed verbatim. The collected data were then analyzed using thematic analysis methodology to identify key themes. Results: Of the 31 participants, 8 (26%) were from lower–middle-income countries, 16 (52%) from upper–middle-income countries, and 7 (22%) from high-income countries. Through thematic analysis, five major categories emerged: (1) AI technology acceptance, (2) disparities in digital transformation, (3) technology governance, (4) data governance, and (5) AI for health system transformation. Participants discussed the promise of AI technology for adoption and integration in the health sector. In lower–middle-income and upper–middle-income countries, disparities in digital transformation—such as infrastructure barriers, market access concerns, and limited investment—were viewed as critical impediments. Across all country income levels, technology and data governance were considered essential for the ethical integration of AI into health care systems. AI is perceived to have the potential to transform health systems, including population health management, service accessibility, operations management, health systems financing and health care payment, and personalized medicine. Conclusions: Our study provides novel perspectives and valuable insights into the current state and future prospects of AI adoption across health systems in SEA. By capturing the experiences and opinions of a broad range of professionals involved in health care and AI, this research provides a nuanced understanding of the opportunities and hurdles associated with health AI in the region. For the full potential of AI-enabled technologies to be successfully implemented and ultimately contribute to the transformation of health systems in the region, foundational investments are needed in digital infrastructure, technology governance, and data governance. These fundamental pillars are crucial for fostering an environment in which AI can be effectively and ethically leveraged to improve health outcomes and strengthen health care systems throughout SEA.

15 January 2024 in JMIR Formative Research
Verified
Journal Article
Open access
LZLu Zheng
Lu Zheng
JOJoshua W Ohde
Joshua W Ohde
SOShauna M Overgaard
Shauna M Overgaard
TBTracey A Brereton
Tracey A Brereton
KJKristelle Jose
Kristelle Jose
YJYoung Juhn
Young Juhn
Background: Personalized asthma management depends on a clinician’s ability to efficiently review patient’s data and make timely clinical decisions. Unfortunately, efficient and effective review of these data is impeded by the varied format, location, and workflow of data acquisition, storage, and processing in the electronic health record. While machine learning (ML) and clinical decision support tools are well-positioned as potential solutions, the translation of such frameworks requires that barriers to implementation be addressed in the formative research stages. Objective: We aimed to use a structured user-centered design approach (double-diamond design framework) to (1) qualitatively explore clinicians’ experience with the current asthma management system, (2) identify user requirements to improve algorithm explainability and Asthma Guidance and Prediction System prototype, and (3) identify potential barriers to ML-based clinical decision support system use. Methods: At the “discovery” phase, we first shadowed to understand the practice context. Then, semistructured interviews were conducted digitally with 14 clinicians who encountered pediatric asthma patients at 2 outpatient facilities. Participants were asked about their current difficulties in gathering information for patients with pediatric asthma, their expectations of ideal workflows and tools, and suggestions on user-centered interfaces and features. At the “define” phase, a synthesis analysis was conducted to converge key results from interviewees’ insights into themes, eventually forming critical “how might we” research questions to guide model development and implementation. Results: We identified user requirements and potential barriers associated with three overarching themes: (1) usability and workflow aspects of the ML system, (2) user expectations and algorithm explainability, and (3) barriers to implementation in context. Even though the responsibilities and workflows vary among different roles, the core asthma-related information and functions they requested were highly cohesive, which allows for a shared information view of the tool. Clinicians hope to perceive the usability of the model with the ability to note patients’ high risks and take proactive actions to manage asthma efficiently and effectively. For optimal ML algorithm explainability, requirements included documentation to support the validity of algorithm development and output logic, and a request for increased transparency to build trust and validate how the algorithm arrived at the decision. Acceptability, adoption, and sustainability of the asthma management tool are implementation outcomes that are reliant on the proper design and training as suggested by participants. Conclusions: As part of our comprehensive informatics-based process centered on clinical usability, we approach the problem using a theoretical framework grounded in user experience research leveraging semistructured interviews. Our focus on meeting the needs of the practice with ML technology is emphasized by a user-centered approach to clinician engagement through upstream technology design.

10 March 2021 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
JOJoshua W. Ohde
Joshua W. Ohde
ZMZubin Master
Zubin Master
JTJon C. Tilburt
Jon C. Tilburt
DWDavid O. Warner
David O. Warner

20 September 2023 in Implementation Science Communications
Verified
Journal Article
Open access
PDF file
JOJoshua W. Ohde
Joshua W. Ohde
DWDavid O. Warner
David O. Warner
JEJason S. Egginton
Jason S. Egginton
HHHildi J. Hagedorn
Hildi J. Hagedorn
Background: Continued tobacco use in cancer patients increases the risk of cancer treatment failure and decreases survival. However, currently, most cancer patients do not receive evidence-based tobacco treatment. A recently proposed “opt-out” approach would automatically refer all cancer patients who use tobacco to tobacco treatment, but its acceptability to cancer patients and providers is unknown. We aimed to understand stakeholder beliefs, concerns, and receptivity to using the “opt-out” approach for tobacco treatment referrals in a cancer care setting. Methods: Semi-structured interviews were conducted with oncology patients, providers, and desk staff. The sample size was determined when theoretical saturation was reached. Given the differences among participant roles, separate interview guides were developed. Transcripts were analyzed using standard coding techniques for qualitative data using the Consolidated Framework for Implementation Research (CFIR) codebook. Emergent codes were added to the codebook to account for themes not represented by a CFIR domain. Coded transcripts were then entered into the qualitative analysis software NVivo to generate code reports for CFIR domains and emergent codes for each stakeholder group. Data were presented by stakeholder group and subcategorized by CFIR domains and emergent codes when appropriate. Results: A total of 21 providers, 19 patients, and 6 desk staff were interviewed. Overall acceptance of the “opt out” approach was high among all groups. Providers overwhelmingly approved of the approach as it requires little effort from them to operate and saves clinical time. Desk staff supported the opt-out system and believed there are clinical benefits to patients receiving information about tobacco treatment. Many patients expressed support for using an opt-out approach as many smokers need assistance but may not directly ask for it. Patients also thought that providers emphasizing the benefits of stopping tobacco use to cancer treatment and survival would be an important factor motivating them to attend treatment. Conclusions: While providers appreciated that the system required little effort on their part, patients clearly indicated that promotion of tobacco cessation treatment by their provider would be vital to enhance willingness to engage with treatment. Future implementation efforts of opt-out systems will require implementation strategies that promote provider engagement with their patients around smoking cessation while continuing to limit burden on providers.